Pharma Stocks Crushed Under Election Rhetoric, but Top Analysts Say Buy These 4 Now
The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income investors have a chance to buy some great stocks on sale.